U.S. Physical Therapy, Inc.
U.S. Physical Therapy, Inc. Fundamental Analysis
U.S. Physical Therapy, Inc. (USPH) shows weak financial fundamentals with a PE ratio of 37.19, profit margin of 5.05%, and ROE of 6.71%. The company generates $0.7B in annual revenue with strong year-over-year growth of 11.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze USPH's fundamental strength across five key dimensions:
Efficiency Score
WeakUSPH struggles to generate sufficient returns from assets.
Valuation Score
WeakUSPH trades at a premium to fair value.
Growth Score
ExcellentUSPH delivers strong and consistent growth momentum.
Financial Health Score
ExcellentUSPH maintains a strong and stable balance sheet.
Profitability Score
WeakUSPH struggles to sustain strong margins.
Key Financial Metrics
Is USPH Expensive or Cheap?
P/E Ratio
USPH trades at 37.19 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, USPH's PEG of 9.46 indicates potential overvaluation.
Price to Book
The market values U.S. Physical Therapy, Inc. at 2.47 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.48 times EBITDA. This is generally considered low.
How Well Does USPH Make Money?
Net Profit Margin
For every $100 in sales, U.S. Physical Therapy, Inc. keeps $5.05 as profit after all expenses.
Operating Margin
Core operations generate 12.77 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.71 in profit for every $100 of shareholder equity.
ROA
U.S. Physical Therapy, Inc. generates $2.79 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
U.S. Physical Therapy, Inc. produces operating cash flow of $69.54M, showing steady but balanced cash generation.
Free Cash Flow
U.S. Physical Therapy, Inc. produces free cash flow of $56.90M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $3.74 in free cash annually.
FCF Yield
USPH converts 4.58% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
37.19
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
9.46
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.47
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.88
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.61
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.20
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.08
vs 25 benchmark
How USPH Stacks Against Its Sector Peers
| Metric | USPH Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 37.19 | 29.45 | Worse (Expensive) |
| ROE | 6.71% | 779.00% | Weak |
| Net Margin | 5.05% | -24936.00% (disorted) | Weak |
| Debt/Equity | 0.61 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.20 | 4.65 | Neutral |
| ROA | 2.79% | -19344.00% (disorted) | Weak |
USPH outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews U.S. Physical Therapy, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
17.95%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-60.87%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
1.62%
Industry Style: Defensive, Growth, Innovation
Growing